ATE5141T1 - Xanthon- und thioxanthonderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. - Google Patents

Xanthon- und thioxanthonderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.

Info

Publication number
ATE5141T1
ATE5141T1 AT79300778T AT79300778T ATE5141T1 AT E5141 T1 ATE5141 T1 AT E5141T1 AT 79300778 T AT79300778 T AT 79300778T AT 79300778 T AT79300778 T AT 79300778T AT E5141 T1 ATE5141 T1 AT E5141T1
Authority
AT
Austria
Prior art keywords
group
groups
effects
formula
carbon atoms
Prior art date
Application number
AT79300778T
Other languages
English (en)
Inventor
Niels Lassen
Klaus Peter Bogeso
Peter Bregnedal Hansen
Jorn Lasse Martin Buus
Allan Johan Bigler
Original Assignee
Kefalas A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kefalas A/S filed Critical Kefalas A/S
Application granted granted Critical
Publication of ATE5141T1 publication Critical patent/ATE5141T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/10—Dibenzothiopyrans; Hydrogenated dibenzothiopyrans
    • C07D335/12—Thioxanthenes
    • C07D335/14—Thioxanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
    • C07D335/18—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Polymerisation Methods In General (AREA)
  • Inks, Pencil-Leads, Or Crayons (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT79300778T 1978-05-12 1979-05-04 Xanthon- und thioxanthonderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. ATE5141T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1931078 1978-05-12
EP79300778A EP0005607B1 (de) 1978-05-12 1979-05-04 Xanthon- und Thioxanthonderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen

Publications (1)

Publication Number Publication Date
ATE5141T1 true ATE5141T1 (de) 1983-11-15

Family

ID=10127259

Family Applications (1)

Application Number Title Priority Date Filing Date
AT79300778T ATE5141T1 (de) 1978-05-12 1979-05-04 Xanthon- und thioxanthonderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.

Country Status (14)

Country Link
US (3) US4285956A (de)
EP (1) EP0005607B1 (de)
JP (1) JPS54154772A (de)
AT (1) ATE5141T1 (de)
AU (1) AU522926B2 (de)
CA (1) CA1127648A (de)
DE (1) DE2966344D1 (de)
DK (1) DK190179A (de)
ES (1) ES480468A1 (de)
FI (1) FI791503A7 (de)
IE (1) IE48261B1 (de)
NO (1) NO150837C (de)
NZ (1) NZ190373A (de)
ZA (1) ZA792250B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4356184A (en) * 1980-06-04 1982-10-26 G. D. Searle & Co. Anti-allergic or antihypertensive 1-piperidinylmethyl benzenamines
US4501749A (en) * 1983-10-31 1985-02-26 Merck & Co., Inc. Peripherally selective dopamine antagonists in the treatment of ocular hypertension
US4777177A (en) * 1984-10-19 1988-10-11 Ciba-Geigy Corporation Pesticidal thioxanthen-9-ylidenepiperidines
US5393890A (en) 1988-06-02 1995-02-28 Ajinomoto Co., Inc. Piperidine derivatives and hypotensives containing the same
US5250681A (en) * 1988-06-02 1993-10-05 Ajinomoto Co., Inc. Piperidine derivatives and hypotensives containing the same
CA2004211A1 (en) * 1988-11-30 1990-05-31 Masataka Syoji Piperidine derivatives and hyportensives containing the same
US7060711B2 (en) * 2001-10-25 2006-06-13 Biofrontera Bioscience Gmbh Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonist
EP1306376A1 (de) * 2001-10-25 2003-05-02 Biofrontera Pharmaceuticals AG Derivaten von 4-(Thio- oder Selenoxanthen-9-yliden)-Piperidin oder Acridine und ihre Verwendung als selektieven 5-HT2B antagonisten
UA86024C2 (ru) 2003-06-27 2009-03-25 Янссен Фармацевтика Н.В. Трициклические дельта-опиоидные модуляторы
CA2574768A1 (en) 2004-08-05 2006-02-05 Janssen Pharmaceutica N.V. Tricyclic delta-opioid modulators
CA2591963A1 (en) 2004-12-22 2006-06-29 Janssen Pharmaceutica N.V. Tricyclic o-opioid modulators
US20060135522A1 (en) * 2004-12-22 2006-06-22 Carson John R Tricyclic delta-opioid modulators
US7589104B2 (en) 2004-12-22 2009-09-15 Janssen Pharmaceutica Nv Tricyclic-bridged piperidinyline derivatives as §-opioid modulators
JP2008526878A (ja) 2005-01-06 2008-07-24 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 三環式δ−オピオイド調節剤
DE602006018604D1 (de) * 2005-06-16 2011-01-13 Janssen Pharmaceutica Nv Tricyclische opioidmodulatoren

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3470188A (en) * 1967-01-05 1969-09-30 Smithkline Corp 9-cycloalkyl-lower alkyl-piperidylidene derivatives of xanthenes and thioxanthenes
US3974285A (en) * 1974-04-10 1976-08-10 Merck & Co., Inc. 10,11-Furo-derivatives of cyproheptadine
US4086350A (en) * 1974-11-06 1978-04-25 Smithkline Corporation Pharmaceutical compositions and method of producing anti-psychotic activity without extrapyramidal symptoms
US4031222A (en) * 1975-12-22 1977-06-21 Merck & Co., Inc. Trifluoromethylthio (and sulfonyl) derivatives of cyproheptadine analogs
US4073912A (en) * 1976-10-12 1978-02-14 Smithkline Corporation Piperidylidene derivatives of benzo-fused xanthenes, thioxanthenes and dibenzoxepins and antipsychotic use thereof

Also Published As

Publication number Publication date
NO150837C (no) 1985-01-09
NO150837B (no) 1984-09-17
US4309429A (en) 1982-01-05
FI791503A7 (fi) 1981-01-01
EP0005607A1 (de) 1979-11-28
DK190179A (da) 1979-11-13
IE791105L (en) 1979-11-12
NZ190373A (en) 1981-12-15
JPS54154772A (en) 1979-12-06
US4285956A (en) 1981-08-25
CA1127648A (en) 1982-07-13
IE48261B1 (en) 1984-11-14
ES480468A1 (es) 1980-07-01
EP0005607B1 (de) 1983-10-26
AU522926B2 (en) 1982-07-01
US4275209A (en) 1981-06-23
NO791592L (no) 1979-11-13
DE2966344D1 (en) 1983-12-01
AU4694179A (en) 1979-11-15
ZA792250B (en) 1980-08-27

Similar Documents

Publication Publication Date Title
ATE5141T1 (de) Xanthon- und thioxanthonderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ES469953A1 (es) Un procedimiento para la preparacion de nuevos derivados de aminoalquilbenceno
ES8307760A1 (es) Un procedimiento para la preparacion de derivados de 4-anilino-pirimidina.
IL78419A (en) Derivatives of diphenylmethane and pyridylphenylmethane
ATE108440T1 (de) Arylaralkylether, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung.
ATE37872T1 (de) Phenylinden-derivate, ihre salze, und verfahren zu ihrer herstellung.
DK5086A (da) Aminoalkylsubstituerede urinstofderivater og enantiomere
ATE7137T1 (de) Nitrosoureum-derivate, verfahren zu deren herstellung, und diese enthaltende pharmazeutische zusammensetzungen.
GB858792A (en) New pyridazine derivatives and processes for their manufacture
GB1498394A (en) Behenic acid esters of 9-thiaxanthene propylidene heterocyclic alcohols and their use in pharmaceutical composition
ATE19879T1 (de) Furyloxazolylessigsaeure-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE3770117D1 (de) Neue 1-/ 3-(2-dialkylaminoaethoxy)-2-thienyl/-3-phenyl-1-propanone und ihre saeureadditionssalze und verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen.
SE8301785L (sv) Sett att framstella 2-tiofen-ettiksyraderivat och mellanprodukter erforderliga for deras framstellning
NZ220294A (en) Heteropolycyclic aromatic amines and pharmaceutical compositions thereof
ATE2793T1 (de) Cephemderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
ES8106526A1 (es) Procedimiento de preparacion de nuevos derivados 15-hidro- xi-e-homoeburnanos halogenados racemicos y opticamente acti-vos y de sus sales de adicion acidas
SE8804696D0 (sv) Dioxazocine derivatives their preparation and compositions containing them
ES8106714A1 (es) Procedimiento de preparar derivados 1,2,4-oxadiacinicos

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee